InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Jewell Christopher M. Director active across 1 company, notably Cartesian Therapeutics, Inc.. In total, 6 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €21k. History available since 2 January 2024. The latest transaction was filed on 10 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Jewell Christopher M is a declarant linked to Cartesian Therapeutics, Inc. (XNAS), where the listed role is Chief Scientific Officer. He has 6 filings in total, and across the 6 recent filings available, the transactions span 2024-01-04 to 2025-01-13, with sales totaling EUR 20584 and the modal transaction nature listed as option exercise.